wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38612833-30FA2C3E-0E12-46C9-BA54-7BE701F37AE2
Q38612833-30FA2C3E-0E12-46C9-BA54-7BE701F37AE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38612833-30FA2C3E-0E12-46C9-BA54-7BE701F37AE2
Early market access of cancer drugs in the EU.
P2860
Q38612833-30FA2C3E-0E12-46C9-BA54-7BE701F37AE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38612833-30FA2C3E-0E12-46C9-BA54-7BE701F37AE2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f2ca6a2e37eb8d811c141e1e4007ef85b9ea4ee4
P2860
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).